Paricalcitol Injection Phase II Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The PK and tolerability of paricalcitol after repeated intravenous administration for 2 weeks (total 6 doses at every HD session) are studied in subjects with 2°HPT who are receiving HD 3 times a week for stable chronic renal failure.
Epistemonikos ID: 44ba878309dafe816fb6ab65926fcf898da3fd66
First added on: May 04, 2024